Valuation : Vivos Therapeutics, Inc.

Market Cap 4.52M 3.91M 3.66M 3.34M 6.29M 432M 6.32M 43.4M 16.94M 218M 16.99M 16.62M 724M P/E 2026 *
-0.17x
P/E 2027 * -0.27x
Enterprise Value 4.52M 3.91M 3.66M 3.34M 6.29M 432M 6.32M 43.4M 16.94M 218M 16.99M 16.62M 724M EV / Sales 2026 *
0.21x
EV / Sales 2027 * 0.13x
Free-Float
72.8%
Yield 2026 *
-
Yield 2027 * -
1 day-12.96%
1 week-24.28%
Current month-45.15%
1 month-46.45%
3 months-66.43%
6 months-83.94%
Current year-88.92%
1 week 0.22
Extreme 0.2211
0.3
1 month 0.22
Extreme 0.2211
0.54
Current year 0.22
Extreme 0.2211
2.69
1 year 0.22
Extreme 0.2211
4.62
3 years 0.22
Extreme 0.2211
48.79
5 years 0.22
Extreme 0.2211
145.97
10 years 0.22
Extreme 0.2211
360.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 2016-08-31
Chief Executive Officer 68 2016-08-31
Director TitleAgeSince
Chairman 68 2020-05-31
Director/Board Member 87 2020-05-31
Director/Board Member 59 2020-05-31
Date Insider Type Main position Quantity % Market Cap.
7/31/26 Free

Chief Financial Officer

400,000 2.8788%
6/30/26
Seneca Partners, Inc.
BuyCompany 2,749,330 19.7870%
6/30/26
Seneca Partners, Inc.
OtherCompany 2,749,330 19.7870%
Change 5-day change 1-year change 3-year change Capi.($)
-12.96%-24.28%-95.15%-96.54% 4.52M
+0.21%-1.08%+18.40%+27.38% 12.67B
+0.81%+1.27%+19.98%+29.02% 7.03B
-1.35%-5.76%+51.37%+28.91% 6.32B
+3.02%-1.71% - - 5.64B
-0.97%-5.83%-12.90%+58.10% 5.14B
-0.30%+3.22%-28.81%-21.57% 3.89B
-0.94%+4.21%+48.19%-4.22% 2.08B
+0.67%+6.19%-17.70%+138.57% 1.77B
+0.32%+4.79%+51.05%-11.31% 1.65B
Average -1.15%-1.93%+3.83%+16.48% 4.62B
Weighted average by Cap. +0.23%-0.86%+16.58%+28.76%

Financials

2026 *2027 *
Net sales 21.79M 18.81M 17.63M 16.1M 30.29M 2.08B 30.44M 209M 81.6M 1.05B 81.8M 80.02M 3.49B 34.09M 29.43M 27.59M 25.19M 47.38M 3.25B 47.61M 327M 128M 1.64B 128M 125M 5.46B
Net income -23.53M -20.32M -19.05M -17.39M -32.71M -2.24B -32.87M -226M -88.13M -1.13B -88.35M -86.42M -3.77B -14.7M -12.69M -11.9M -10.86M -20.44M -1.4B -20.54M -141M -55.06M -709M -55.2M -54M -2.35B
Net Debt - -
Logo Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Employees
268
Date Price Change Volume
26-08-28 US$0.2249 -12.96% 4,731,162
26-08-27 US$0.2584 +1.81% 1,783,837
26-08-26 US$0.2538 -4.30% 15,185,135
26-08-25 US$0.2652 -4.19% 1,771,807
26-08-24 US$0.2768 -6.80% 249,002
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.2249USD
Average target price
2.117USD
Spread / Average Target
+841.16%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VVOS Stock